Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001824618-21-000003
Filing Date
2021-10-25
Accepted
2021-10-25 10:15:11
Documents
1
Effectiveness Date
2021-10-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10186
  Complete submission text file 0001824618-21-000003.txt   11207
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617- 281-5658
Cedilla Therapeutics, Inc. (Filer) CIK: 0001824618 (see all company filings)

EIN.: 822647784 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-376252 | Film No.: 211342471